DIFFUSE LARGE B-CELL LYMPHOMA STAGE I

DIFFUSE LARGE B-CELL LYMPHOMA STAGE I was reported 42 times

These drug classes are most commonly taken by patients reporting DIFFUSE LARGE B-CELL LYMPHOMA STAGE I:

# Drug Count
0 Corticosteroid [EPC] 17
1 Folate Analog Metabolic Inhibitor [EPC] 8
2 Purine Antimetabolite [EPC] 7
3 Calcineurin Inhibitor Immunosuppressant [EPC] 5
4 Nonsteroidal Anti-inflammatory Drug [EPC] 5
5 Tumor Necrosis Factor Blocker [EPC] 5
6 Alkylating Drug [EPC] 4
7 Vitamin B12 [EPC] 4
8 Vitamin C [EPC] 4
9 Vitamin D [EPC] 4
10 Benzodiazepine [EPC] 3
11 CD20-directed Cytolytic Antibody [EPC] 3
12 Aminosalicylate [EPC] 2
13 Angiotensin 2 Receptor Blocker [EPC] 2
14 HMG-CoA Reductase Inhibitor [EPC] 2
15 Integrin Receptor Antagonist [EPC] 2
16 Kinase Inhibitor [EPC] 2
17 Platelet Aggregation Inhibitor [EPC] 2
18 Provitamin D2 Compound [EPC] 2
19 mTOR Inhibitor Immunosuppressant [EPC] 2
20 Antimetabolite Immunosuppressant [EPC] 1
21 Azole Antifungal [EPC] 1
22 Calcium Channel Blocker [EPC] 1
23 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
24 Dihydropyridine Calcium Channel Blocker [EPC] 1
25 Fluoroquinolone Antibacterial [EPC] 1
26 GLP-1 Receptor Agonist [EPC] 1
27 Janus Kinase Inhibitor [EPC] 1
28 Loop Diuretic [EPC] 1
29 Nitrofuran Antibacterial [EPC] 1
30 Parathyroid Hormone-Related Peptide Analog [EPC] 1
31 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
32 Phosphodiesterase 4 Inhibitor [EPC] 1
33 Platinum-based Drug [EPC] 1
34 Serotonin-3 Receptor Antagonist [EPC] 1
35 Sulfonamide Antibacterial [EPC] 1
36 Sulfonamide Antimicrobial [EPC] 1
37 Sulfonylurea [EPC] 1
38 Thalidomide Analog [EPC] 1
39 Topoisomerase Inhibitor [EPC] 1
40 Xanthine Oxidase Inhibitor [EPC] 1
41 beta3-Adrenergic Agonist [EPC] 1
42 gamma-Aminobutyric Acid A Receptor Agonist [EPC] 1